PICBP Antibody
Description
Biological Role of PCBP1
PCBP1 is involved in:
-
RNA Binding: Contains three KH domains for RNA interactions, stabilizing mRNAs like α-globin and viral RNAs (e.g., poliovirus) .
-
Viral Replication: Facilitates replication of hepatitis A and human papillomavirus via RNA interactions .
-
Oxidative Stress Regulation: Modulates iron metabolism by binding iron-responsive elements .
Key Findings
-
Diagnostic Utility: PCBP1 antibodies detect overexpression in cancers, including gliomas and hepatocellular carcinoma, correlating with poor prognosis .
-
Viral Studies: Used to map PCBP1’s role in poliovirus RNA replication and hepatitis A virus translation .
-
Mechanistic Insights: Antibodies enable study of PCBP1’s interaction with 15-lipoxygenase mRNA, critical for inflammatory responses .
Validation Data
-
Specificity: No cross-reactivity with other proteins confirmed via immunoblotting .
-
Sensitivity: Detects PCBP1 at concentrations as low as 0.1 ng in ELISA .
Technical Considerations
-
Storage: Lyophilized antibodies stable at -20°C for 1 year; reconstituted aliquots stable for 6 months .
-
Limitations: Requires epitope retrieval for formalin-fixed tissues in IHC .
Emerging Research Directions
Product Specs
Target Background
KEGG: ath:AT5G04020
UniGene: At.33187
Q&A
Here’s a structured collection of FAQs tailored for academic researchers investigating ribosomal-targeting antibodies, informed by the scientific depth and methodologies in the provided sources:
Advanced Research Challenges
Approach:
-
Epitope binning: Classify targets using 28S/18S/5.8S rRNA variants (e.g., SEQ ID NO:1)
-
Bispecific formats: Combine rRNA-binding arms with effector-recruitment domains (Figure 3 in )
-
Computational optimization: Energy function modeling to disentangle binding modes for cross-reactive ligands
Case example:
-
Observation: Antibody X induces apoptosis without cell cycle arrest vs. arrest + apoptosis
-
Resolution framework:
| Variable | Analytical Method | Critical Parameters |
|---|---|---|
| Cell type | RNA-seq | Ribosomal biogenesis genes (e.g., POLR1A) |
| Exposure time | Live-cell imaging | Duration of JNK/p38 activation |
| Formulation | PK/PD modeling | Tissue penetration vs. target engagement |
Key: Contradictions often stem from cell-type-specific ribosomal biology or antibody valency .
Methodology from :
-
Energy function optimization:
-
Cross-specific: Minimize E(desired ligands)
-
Mono-specific: Minimize E(target) + maximize E(off-targets)
-
-
Phage display validation: Test predicted variants against 28S/18S rRNA mutants
Critical parameters:
-
Epitope chemical similarity (ΔG < 2 kcal/mol requires multi-modal modeling)
-
Library diversity depth (>10^10 variants for sub-nM discrimination)
